EUVIMEDEUVIMED entdecken
Crossref

Is Outpatient Totally Tubeless Standard Percutaneous Nephrolithotomy Safe and Efficacious?

Kavita Gupta, Nir Tomer, Christopher Connors, Susan Gong iD, Raymond Khargi, Blair Gallante, William M Atallah, Mantu Gupta iD

Journal of Endourology · 2025

DOI: 10.1089/end.2024.0441 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Endourology, 2025. Verfasst von Kavita Gupta und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Icahn School of Medicine at Mount Sinai, New York, New York, USA. Hauptthemen laut MEDLINE: Nephrolithotomy, Percutaneous, Outpatients, Ambulatory Surgical Procedures. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 15 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction and Objectives: Percutaneous nephrolithotomy (PCNL) is the gold standard treatment for large, complex intrarenal stones. Tubeless PCNL (t-PCNL) where no nephrostomy tube is placed and totally tubeless PCNL (tt-PCNL) in selected patients have been well described. There has been no study to our knowledge discharging patients the same day totally tubeless. In this study, we describe our experience with tt-PCNL on a totally outpatient basis-with the patient going home with absolutely no tube, catheter, or stent, evaluating its safety and efficacy vis-à-vis a comparison with outpatient t-PCNL patients discharged with an indwelling stent.

Methods

We prospectively collected data from 130 consecutive patients scheduled for outpatient PCNL from August 2023 to January 2024. Demographics, stone characteristics, and intraoperative data were compared. Outcomes included postoperative (post-op) pain, stone-free rate (SFR), 30-day complications, and ED visits or readmissions. Categorical variables were compared using Chi-square or Fisher's exact tests and continuous variables via Mann-Whitney U tests.

Results

After exclusions, 53 patients underwent tt-PCNL and 50 had t-PCNL. Demographics and stone burden did not differ between groups. No visceral or pleural injuries occurred in either group. Post-op transfusion rates, SFR, 30-day complications, ED visits, and readmissions were also comparable between the two groups. The mean operative (OR) time and incidence of Clavien-Dindo I complications were higher with t-PCNL with stent (80 minutes vs 58 minutes, p < 0.001,16% vs 3.8%, p = 0.048). Post-op pain scores and postanesthesia care unit stay times were similar.

Conclusions

In this first ever comparison of outpatient t-PCNL to tt-PCNL, we found the same-day discharge of tt-PCNL patients to be safe and effective. Stent omission in our patients did not increase the risk of RF, ED visits, complications, or readmissions. A large, multicenter, randomized prospective controlled trial will help to confirm our findings.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Nephrolithotomy, PercutaneousOutpatientsAmbulatory Surgical ProceduresHumansFemaleMaleMiddle AgedTreatment OutcomeKidney CalculiPostoperative ComplicationsAdultAgedProspective Studies

Stichwörter der Autor:innen

PCNLsupinetubeless

Autor:innen und Institutionen

  • Department of Urology, Icahn School of Medicine at Mount Sinai, New York, New York, USA.

ORCID-Profile: Susan Gong, Mantu Gupta

Zitieren

APA

Gupta, K., Tomer, N., Connors, C., Gong, S., Khargi, R., Gallante, B., Atallah, W. M., & Gupta, M. (2025). Is Outpatient Totally Tubeless Standard Percutaneous Nephrolithotomy Safe and Efficacious?. Journal of Endourology. https://doi.org/10.1089/end.2024.0441

Vancouver

Gupta K, Tomer N, Connors C, Gong S, Khargi R, Gallante B, et al. Is Outpatient Totally Tubeless Standard Percutaneous Nephrolithotomy Safe and Efficacious?. Journal of Endourology. 2025. doi:10.1089/end.2024.0441

BibTeX
@article{Gupta2025,
  author = {Gupta, Kavita and Tomer, Nir and Connors, Christopher and Gong, Susan and Khargi, Raymond and Gallante, Blair and Atallah, William M and Gupta, Mantu},
  title = {Is Outpatient Totally Tubeless Standard Percutaneous Nephrolithotomy Safe and Efficacious?},
  journal = {Journal of Endourology},
  year = {2025},
  doi = {10.1089/end.2024.0441}
}
Kostenlos starten →